Gemma Reynolds

Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma

A. Grigg, E. Cliff, Gemma Reynolds, 2023, Clinical Hematology International.

Hepatitis B reverse seroconversion despite entecavir prophylaxis in a myeloma patient on multiple novel agents: a case report and review of the literature

S. Harrison, A. Spencer, B. Teh, 2020, Leukemia & lymphoma.

Latent infection screening and prevalence in cancer patients born outside of Australia: a universal versus risk-based approach?

K. Thursky, G. Haeusler, M. Slavin, 2021, Supportive Care in Cancer.

Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns

M. Slavin, B. Teh, Gemma Reynolds, 2020, Leukemia & lymphoma.

Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma.

A. Kesselheim, R. Popat, G. R. Mohyuddin, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vaccine schedule recommendations and updates for patients with hematologic malignancy post-hematopoietic cell transplant or CAR T-cell therapy.

B. Teh, V. Hall, Gemma Reynolds, 2023, Transplant infectious disease : an official journal of the Transplantation Society.

Predicting infections in malignant haematology patients treated with CAR-T therapies: A systematic scoping review and narrative synthesis.

K. Thursky, T. Spelman, M. Slavin, 2023, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Recommendations on prevention of infections in patients with T-cell lymphomas: a narrative review and synthesis

K. Thursky, B. Teh, Gemma Reynolds, 2023, Leukemia & lymphoma.